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Glial ﬁbrillary acidic protein (GFAP) is a principal intermediate ﬁlament in mature astrocytes of the
central nervous system (CNS), and the regulation of GFAP transcription has not been well under-
stood yet. In the present study, we reported paired box 3 protein (Pax3) as a novel regulator of GFAP
transcription, which could bind the promoter region of GFAP and down regulate the GFAP level dur-
ing the serum-induced astrocyte differentiation of neural stem cells (NSCs). Moreover, the overex-
pression and suppression of Pax3 could inhibit and promote NSC differentiation, respectively.
These data suggest that Pax3 negatively regulates GFAP expression during astrocyte differentiation
in vitro.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glial ﬁbrillary acidic protein (GFAP) is the major intermediate
ﬁlament protein in mature astrocytes, and it likely plays a critical
role due to its high abundance in astrocytes and strong conserva-
tion among vertebrates. Numerous reports have recently focused
on the regulation of GFAP expression. The extracellular signals that
may activate GFAP expression include ciliary neurotrophic factor,
pituitary adenylate cyclase-activating polypeptide, and bone mor-
phogenetic proteins [1–4]. Furthermore, the regulatory elements in
the GFAP gene have been examined to understand how these sig-
nals affect astrocyte maturation and GFAP expression. Transcrip-
tion factors such as AP-1 [5], NF-1, STAT, and Smad [3,6,7] have
been reported to bind to the promoter region of GFAP. In our pre-
liminary study, the promoter region of GFAP was analyzed with
Genomatix software to identify new transcription factors that
may regulate GFAP expression. Two potential Pax3 protein-binding
sites were identiﬁed that contain well-recognized DNA motifs.
Members of the Pax gene family are reported to be key
regulators of the formation of multiple tissues and organs duringchemical Societies. Published by E
n; Pax3, paired box gene 3;
y shift assay; ChIP, chromatinembryonic development. Pax3 is expressed in the limb muscle,
neural tube and neural crest, and is required for the migration
and differentiation of muscle precursor cells and neural crest cells
[8]. Pax3 is mutated in Splotch mice and humanWaardenburg syn-
drome, in which malformation of neural tube, somite derivatives,
and limb muscles occurs, and the homozygous Splotch mutations
are mid-gestation lethal [9,10]. In primary Schwann cell cultures,
constitutive expression of Pax3 alters levels of GFAP expression
[11], which is consistent with the idea that Pax3 may regulate
GFAP expression. Thus, in our current study, we analyzed the pro-
moter region of rat GFAP gene, and identiﬁed two elements that
could bind Pax3, which further negatively regulates GFAP expres-
sion during astrocyte differentiation in vitro.
2. Materials and methods
2.1. Bioinformatics analysis and plasmid construction
The promoter region spanning from 1987 to +13 bp of the rat
GFAP gene (the start site of transcription is referred as the position
1) [12] was analyzed by Genomatix software (http://www.genom-
atix.de) to identify potential binding sites for transcription factors.
The full length promoter plasmid pGFAP2000 spanning from
1987 to +13 bp of rat GFAP genomic DNA was cloned into
pGL3-Basic luciferase reporter vector (Promega). The nucleotides
corresponding to P1 and P2 probes (listed in Table 1) in pGFAP2000
were deleted singly or in combination to generate the mutatedlsevier B.V. All rights reserved.
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Pfu Turbo DNA polymerase from a QuikChange kit (Stratagene).
The mutated promoter constructs were termed pGFAP2000-DelP1
(19 nucleotides deletion of P1), pGFAP2000-DelP2 (19 nucleotides
deletion of P2) and pGFAP2000-DelP1P2 (38 nucleotides deletion
of P1 and P2), respectively. The cDNA fragment encoding rat
Pax3 was also cloned into the pCI vector (Promega) for ectopic
expression. All of these constructs were conﬁrmed by sequencing.
2.2. Cell culture, transfections, and luciferase assays
HEK 293T cells and RSC96 cells were purchased from the Amer-
ican Type Culture Collection (ATCC) and cultured in the recom-
mended medium and conditions. Luciferase reporter assays were
performed by co-transfecting normal or mutated GFAP promoter
reporter plasmid, together with the PRL (Promega) vector, into
RSC96 cells in triplicate using Lipofectamine2000 (Invitrogen).
The cell lysates were analyzed for luciferase activity using the Dual
Luciferase Assay Kit according to the manufacturer’s speciﬁcations.
2.3. Electrophoretic mobility shift assay
Nuclear extracts from HEK 293T cells transfected with pCI-Pax3
were prepared, and electrophoreticmobility shift assays (EMSAs)
were performed exactly as described [2,6]. The sequences of the
normal and mutated oligonucleotides used in this experiment are
listed in Table 1. For supershift experiments, nuclear extracts were
pre-incubated with anti-Pax3 polyclonal antibodies (sc-34918,
Santa Cruz Biotechnology) before adding the labeled probes.Table 1
Oligonucleotides used in the study.
Usage Targets Sequence (50 to 30)
RT-PCR GAPDH-sense ctgcccagaacatcatccct
GAPDH-antisense tgaagtcgcaggagacaacc
Pax3-sense gccaatcaactgatggcttt
Pax3-antisense cattcgaaggaatggtgctt
GFAP-sense gactatcgccgccaactg
GFAP-antisense atgacctcgccatcccg
Reporter construct pGFAP2000-sense cgagctcctctccacattcc
caactcatagg
pGFAP2000-antisense cccaagcttttgccctgcttc
tgctggctcctg
mutant construct Del P1-sense gtcactggggccagaaaatc
ccgaaggggc
Del P1-antisense gccccttcgggattttctgg
ccccagtgac
Del P2-sense cccctgggacctgggattgga
agcctact
Del P2-antisense agtaggcttccaatcccaggt
cccagggg
Expression vector pCI-Pax3-sense ggaattcatgaccacgct
ggccgg
pCI-Pax3-antisense acgcgtcgacgaacgtcca
cggcttac
Pax3 shRNA sequence Pax3 shRNA-sense agctgggaaatcagagacaaa
Pax3 shRNA-antisense tttgtctctgatttcccagct
EMSA P1 probe-sense gtggtcacacaagccttta
P1 probe-antisense taaaggcttgtgtgaccac
P2 probe-sense tgccaattagtgtgaccca
P2 probe-antisense tgggtcacactaattggca
P1M probe-sense gtgggacaacaagccttta
P1M probe-antisense taaaggcttgttgtcccac
P2M probe-sense tgccaattagttgtcccca
P2M probe-antisense tggggacaactaattggca
ChIP P1 ChIP-sense ccacattcccaactcatag
P1 ChIP-antisense acctttagactggacctcat
P2 ChIP-sense gcagtttacccaaccca
P2 ChIP-antisense gccacagagcgaatacaa2.4. Neural stem cell cultures and differentiation
Neural stem cells (NSCs) were derived from the cerebral cortex
of E16 Sprague–Dawley rats as described previously and grown as
neurospheres [13]. To induce differentiation, neurospheres or dis-
persed NSCs were seeded onto either dishes or coverslips coated
with poly-L-lysine and cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM/F12) with 1% fetal bovine serum (FBS). Astrocyte
differentiation was examined 3 days later.
2.5. Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were performed
with a commercial kit (Upstate Biotechnology) as described by
the manufacturer. Normal and differentiated NSCs were lysed,
and the immunoprecipitation was performed with anti-Pax3
(sc-34918) polyclonal antibodies (Santa Cruz Biotechnology) or
mouse immunoglobulin G (IgG; negative control). The oligonu-
cleotide primers for polymerase chain reaction (PCR) that were
used to detect the fragment of the promoter region of GFAP are
listed in Table 1.
2.6. Pax3 knockdown, overexpression, and adenoviral infections
The target sequences used to knockdown Pax3 by shRNA inter-
ference are listed in Table 1. The shRNA fragments were subcloned
into the pYrbio-hU6-EGFP-shRNA vector (Changsha Yingrun Bio-
tech. Co. Ltd.), which can be used as an entry vector for adenovirus
construction. The pAd/CMV/V5-DEST™ vector (Invitrogen) was
used to generate recombinant adenovirus, and the adenovirus
packaging was performed with ViraPower™ Adenoviral Expression
System (Invitrogen). The Pax3 overexpression adenoviral construct
was synthesized as well. The adenoviral construct was used to pro-
duce recombinant viruses, which were used to infect the NSCs.
Then, the neurospheres were transferred onto glass coverslips in
24-well dishes containing DMEM/F12 medium with 1% FBS for
Pax3-expressed virus infection, or with 2% B27 for shPax3 virus
infection in the absence of serum. After additional culturing for
3 days, the neurospheres were ﬁxed and processed for immunocy-
tochemistry followed by confocal microscopy observation.
2.7. Immunocytochemistry
The cultured cells were ﬁxed in 4% paraformaldehyde for
20 min and then incubated with polyclonal primary antibody to
rabbit anti Pax3 (1:200, LifeSpan BioSciences) and monoclonal pri-
mary antibody to GFAP (1:400, Millipore) at 4 C overnight. Fluo-
rescence (Cy3 or FITC)-labeled secondary antibodies were added
and further incubated, followed by visualization with confocal
microscopy.
2.8. RT-PCR and western blot analysis
Total RNA was extracted from cells with Trizol (Invitrogen),
and cDNA was synthesized from total RNA using an Omniscript
RT kit (QIAGEN) following the supplier’s instructions. The se-
quences of the primers for Pax3, GFAP, and GAPDH (as an internal
control) used in RT-PCR are shown in Table 1, and the cycle num-
bers used for ampliﬁcation were 35, 30 and 25, for Pax3, GFAP,
and GAPDH, respectively. Western blotting was performed accord-
ing to standard protocols. The antibodies used were goat anti-
GAPDH polyclonal antibody (1:800, Santa Cruz Biotechnology),
rabbit anti-Pax3 polyclonal antibody (1:1000, LifeSpan BioSci-
ences), rabbit anti-GFAP polyclonal antibody (1:400, Dakocytoma-
tion), donkey anti-goat IRDye (1:10 000, Rockland), and donkey
anti-rabbit IRDye (1:10 000, Rockland). The immunblots were
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DH was used as an internal control for normalizing the protein
load.
3. Results
3.1. Identiﬁcation of Pax3 binding elements in the GFAP promoter and
EMSA assay
The promoter region of the rat GFAP gene was analyzed by Gen-
omatix software to identify potential binding sites for transcription
factors. Two potential Pax3 protein binding sites, designated P1
(50-gtggTCACacaagccttta-30, spanning from 1935 to 1917 bp
on the positive strand) and P2 (50-tgggTCACactaattggca-30, span-
ning from 416 to 434 bp on the minus strand), were identiﬁed
by the matrices database of transcription factor binding sites. The
IUPAC string consensus is a representation of the matrix, which
was described as follows: 50-bnwgTCACactdvynwtn-30 (B: G/T/C,
N: A/G/C/T, W: A/T, D: G/A/T, V: G/C/A, Y: T/C). Nucleotides in cap-
ital letters of the IUPAC string consensus denote the core sequence
used by the software, and the core sequence of a matrix is deﬁned
as the (usually 4) highest conserved, consecutive positions of the
matrix. The consensus sequence also coincides with the well-
deﬁned Pax3 binding motif that had been reported previously
[14]. To determine whether the identiﬁed cis-element can recruit
transcription factors to regulate promoter activity, EMSA was per-
formed with nuclear extracts from pCI-Pax3 transfected HEK293T
cells (Fig. 1A). The double-stranded oligonucleotides correspond-
ing to the predicted cis-element in the GFAP promoter formed se-
quence-speciﬁc DNA–protein complexes with the nuclear
extracts of Pax3-expressing HEK293T cells, while the mutated P1
and P2 probes failed to generate such a DNA–protein complex
(Fig. 1A) in the EMSA. Finally, we performed EMSA supershift anal-
ysis with nuclear extracts from pCI-Pax3-transfected HEK
293Tcells and anti-Pax3 antibody. The presence of the anti-Pax3
antibody generated the supershifted band (Fig. 1B). These results
indicate that Pax3 binds to P1 and P2 elements on the GFAP
promoter.
3.2. P1 and P2 are negative regulatory elements for GFAP transcription
To address the effect of P1 and P2 elements on GFAP transcrip-
tion, we constructed three recombinants containing normal and
mutated promoters of GFAP, and performed luciferase reporter
gene assays to elicit their effect. The RSC96 cell line is a spontane-
ously transformed rat Schwann cell line derived from long-term
culture of rat primary Schwann cells [15], and it was used for lucif-
erase assay due to its endogenous expression of Pax3, even though
at a low level. The normal pGFAP2000 luciferase promoter con-
struct showed low transcription activity, while absence of P1 or/
and P2 in the promoter resulted in an obvious increase of tran-
scription activity (Fig. 1C). These results indicate that these Pax3
binding sequences are negative regulatory elements for GFAP
transcription.
3.3. Pax3 inhibits GFAP expression in RSC96 cells
Subsequently, we performed RT-PCR and western blotting to
measure the mRNA and protein expression levels of GFAP in both
Pax3-overexpressing RSC96 cells and control RSC96 cells. RSC96
cells showed endogenous expression of GFAP as well, and the
ectopically expressed Pax3 decreased the GFAP level. The results
indicated that the expression of Pax3 is inversely related to the
expression of GFAP both at the mRNA and protein levels (Fig. 1D
and E), suggesting that Pax3 negatively regulates GFAP gene
expression.3.4. Pax3 negatively regulates GFAP expression during astrocyte
differentiation
GFAP expression is a characteristic marker of astrocyte matura-
tion, and we asked whether Pax3-mediated regulation is involved
in this process. The serum-induced astrocyte differentiation model
was applied in our study. In our preliminary study, non-speciﬁc
staining of Pax3 antibody to neurospheres was observed. There-
fore, we used only dispersed NSCs in this experiment, while intact
neurospheres were used in the following assays. NSCs derived from
the cerebral cortex were nestin (data not shown) and Pax3 positive
but GFAP negative, and they differentiated into GFAP-positive
astrocytes in response to FBS (Fig. 2A and B). The differentiated
astrocytes were positively stained by S100beta antibody as well
(Supplementary data). We further measured Pax3 and GFAP level
of NSCs before and after differentiation by Immunocytochemistry
and RT-PCR. After differentiation, the expression of Pax3 clearly de-
creased. The signal could not be detected by immunostaining, and
only a weak band was observed by RT-PCR owing to the high sen-
sitivity of PCR. In the meantime, the expression of GFAP increased
dramatically (Fig. 2C), which suggests a negative regulatory role of
Pax3 on the GFAP expression.
3.5. Pax3 binds the promoter region of endogenous GFAP in NSCs
The next question was whether Pax3 could bind to the pro-
moter region of endogenous GFAP in the context of native chroma-
tin. Therefore, a ChIP assay was performed to address this issue.
The Pax3 antibody speciﬁcally immunoprecipitated a Pax3–DNA
complex in the proximal region of the GFAP promoter, and the
binding of Pax3 to the P1 and P2 regions was subsequently demon-
strated by PCR performed with speciﬁc primers in both undifferen-
tiated and differentiated NSCs (Fig. 3). The results indicated that
Pax3 indeed occupies the promoter region of GFAP before the dif-
ferentiation response is triggered, and the binding could not be de-
tected after GFAP expression had been initiated. The results further
support the idea that Pax3 functions in transcriptional regulation.
3.6. The effect of overexpression and suppression of Pax3 on astrocyte
differentiation
Finally, we examined whether overexpression and suppression
of Pax3 modulated the differentiation of NSCs. NSCs were regarded
to be differentiated when the neurospheres were attached and cell
spreading was observed, and the NSCs remaining as neurospheres
were taken as undifferentiated. Overexpression of Pax3 dramati-
cally inhibited astrogliogenesis and promoted maintenance of
NSCs. GFAP expression was also suppressed as expected
(Fig. 4A1, A2 and A3). However, when endogenous Pax3 was
knocked down in neurospheres with shRNA, GFAP (Fig. 4B1, B2
and B3) and S100beta (Supplementary data) expression were ob-
served, which indicates that astrocyte differentiation occurred in
the absence of FBS. These results imply a critical role for Pax3
not only in GFAP expression, but also in the maintenance of the
undifferentiated state of NSCs.4. Discussion
GFAP has previously been considered to be directly correlated
with Pax3 expression in sciatic nerve repair, serving as a positively
regulated target of Pax3 [16]. However, no supporting evidence fo-
cused on the transcriptional relationship between Pax3 and GFAP
has been reported. Here, we ﬁrst identiﬁed two Pax3 binding ele-
ments in GFAP promoter and demonstrated that Pax3 inhibits GFAP
transcription in RSC96 cells (spontaneously transformed Schwann
Fig. 1. Pax3 binds to the P1 and P2 elements in the GFAP promoter and negatively regulates GFAP expression in vitro. (A) Nuclear extracts from HEK293T cells ectopically
expressing Pax3 were incubated with biotin labeled probes corresponding to P1 and P2 elements, respectively, to determine whether they could form the complex. In both P1
and P2 panels, Lane 1, negative control with probe only. Lane 2, 3 and 4, nuclear extracts from pCI-Pax3 transfected HEK293T cells. Lane 3, nuclear extracts were incubated
with 200-fold molar excess unlabelled oligonucleotide of identical probe sequence in addition (self competitor). Lane 4, nuclear extracts were incubated with mutated P1 or
P2 oligonucleotide (P1M and P2M) (mutation within the core Pax3 binding domain). (B) Anti-Pax3 antibody or goat IgG was added to the reactions for supershift analysis
(Lanes 2 and 3). Protein–DNA complexes and antibody-protein–DNA complexes that supershifted are shown with arrows. SS, supershifted complex. (C) Effect of Pax3 on
transcriptional activity of the GFAP promoter. The different rat GFAP reporter constructs were co-transfected into RSC96 cells for the luciferase assay. Mutated promoters that
speciﬁcally delete Pax3 binding elements were introduced into RSC96 cells. Fireﬂy luciferase expression levels were normalized to the luciferase activity of internal Renilla
control. The results are the means ± standard deviation (S.D.) of three separate experiments performed in triplicate for each group. One-way analysis of variance (ANOVA) was
used for statistical analysis. ⁄⁄P < 0.01. The results indicate that both P1 and P2 elements are negative regulatory elements. (D) The effect of Pax3 overexpression on the mRNA
level of GFAP in RSC96 cells. The mRNA levels of GFAP after transient transfection of pCI-Pax3 or control pCI-neo were analyzed by RT-PCR. (E) The effect of Pax3
overexpression on the protein level of GFAP in RSC96 cells. The protein levels of GFAP after transient transfection of pCI-Pax3 or control pCI-neo, were analyzed by Western
blotting. A t-test was used for statistical analysis, and the results are shown as means ± S.D. ⁄p < 0.05 vs pCI-neo, n = 3.
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Fig. 2. The expression of Pax3 and GFAP in control and differentiated NSCs. (A) Control NSCs were labeled with speciﬁc antibody or probes (green; GFAP, red; Pax3, blue;
Hoechst). (B) The NSCs differentiated into GFAP-positive astrocytes upon serum treatment for 3 days. (C) RT-PCR was performed to measure Pax3 and GFAP level in control
and differentiated NSCs. A t-test was used for statistical analysis, and the results are shown as means ± S.D. ⁄p < 0.05; ⁄⁄P < 0.01 vs NSC, n = 3.
Fig. 3. Chromatin immunoprecipitation assays indicating that Pax3 occupied the
promoter of the endogenous GFAP gene in undifferentiated NSCs, but not in
differentiated NSCs (FBS medium). The speciﬁc anti-Pax3 antibody or control
normal mouse IgG was used for immunoprecipitations. The products of PCR
ampliﬁcations for P1 (159 bp) and P2 (358 bp) from the proximal region of the GFAP
promoter are shown.
1018 Y. Liu et al. / FEBS Letters 585 (2011) 1014–1020cells). Since GFAP is the major intermediate ﬁlament protein in ma-
ture astrocytes, and GFAPmRNA has been reported to initiate from
a different site in Schwann cells than in astrocytes, the transcrip-
tion of GFAP may differ between Schwann cells and astrocytes
[17,18]. We further determined the effect of Pax3 on astrocyte dif-
ferentiation and GFAP expression. Our results indicated that Pax3acts as a transcriptional repressor during serum-induced astrocyte
differentiation of NSCs. Pax3 was also reported to be a negative
regulator of terminal differentiation by binding to sites located up-
stream of the myelin basic protein (MBP) promoter [11]. Hence, it
is reasonable to speculate that Pax3 represses expression of GFAP
during embryonic development. In addition, the Pax3 binding sites
were also identiﬁed in the promoter of mouse and human GFAP
gene with the same consensus motif by Genomatix software, with
the binding sites being located 6.5 and 8.5 Kb upstream of tran-
scription start site in mouse and human, respectively. This sup-
ports the generality of our reported ﬁndings among different
species.
The requirement of a decrease in Pax3 for appropriate expres-
sion of GFAP during astrocytogenesis is suggested by our observa-
tions that neurospheres infected with Pax3-expressing adenovirus
failed to differentiate into astrocytes in response to serum. These
observations are consistent with reports that Pax3 is required for
maintaining cells in an undifferentiated state. A well-known exam-
ple is that persistent maintenance of Pax3 expression in neural
crest cells blocks neural crest-derived osteoblast differentiation
[19]. Our data show that suppression of Pax3 by shRNA induced
astrocyte differentiation of NSCs without serum. Similarly, neural
crest cells in Splotch mice were reported to undergo premature
neurogenesis [20], and downregulation of Pax3 in neural crest cul-
tures inhibits sensory neuron differentiation without affecting sur-
vival of sensory neurons or precursor populations [21].
It is now well recognized that transcriptional regulation is an
extremely complex and tightly controlled process and is the result
Fig. 4. Pax3 negatively regulates astrocyte differentiation of NSCs. (A) Overexpression of Pax3 inhibited NSCs induced to differentiate by 1% FBS. (A1) The neurospheres
infected with control GFP-adenovirus differentiated upon serum treatment for 3 days. (A2) Differentiation of neurospheres infected with Pax3-adenovirus was dramatically
inhibited. (A3) The ratio of differentiated/undifferentiated neurospheres is shown as means ± S.D. from three independent experiments. Statistical analysis was performed
using a t-test, ⁄⁄P < 0.01 vs. control. (B) Suppression of Pax3 by shRNA in NSCs stimulated astrocyte differentiation of NSCs. (B1) Neurospheres infected with control GFP-
adenovirus remained undifferentiated after incubation in serum-free medium for 3 days. (B2) Neurospheres infected with shPax3-adenovirus underwent differentiation after
3 days in the absence of serum. (B3) The ratio of differentiated neurospheres is shown as means ± S.D. from three independent experiments. Statistical analysis was
performed using a t-test, ⁄⁄P < 0.01 vs. control.
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actual transcription level of a gene is determined by a combination
of cis-elements and trans-factors available within cells during acertain physiological or pathological process. Pax3 physically inter-
acts with the transcription factor Sox10 to specify melanoblasts
from neural crest cells [22]. The binding sites of Sox family
1020 Y. Liu et al. / FEBS Letters 585 (2011) 1014–1020transcription factors were also identiﬁed in the promoter region
of GFAP by Genomatix software (http://www.genomatix.de).
Whether they are involved in transcription suppression is an inter-
esting issue for future study.
In conclusion, we have ﬁrst shown that Pax3 binds to the GFAP
promoter and negatively regulates GFAP expression and astrocyte
differentiation from NSCs. Pax3 can be considered a regulator of
NSC differentiation and may determine cell fate and simulta-
neously maintain an undifferentiated state, leaving the cells poised
to differentiate in response to external stimuli. An important focus
for future investigations will be to identify the upstream regulators
of Pax3 genes during serum-induced astrocyte differentiation of
NSCs, which will link the extracellular signal to the expression of
GFAP and should further facilitate our understanding of the tran-
scriptional mechanism of GFAP gene.
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